About
Ousia, from the Greek for "essence"; Ousia Pharma emerged from a groundbreaking academic discovery at University of Copenhagen and rapidly evolved into a biotechnology company. We are pioneering innovative therapeutic strategies centered on peptide-drug conjugates to improve the lives of patients with cardiometabolic diseases.
Who are we?
Ousia Pharma ApS is a Danish biotech start-up focused on the development of novel peptide-drug conjugates for the treatment of metabolic diseases. We utilize a targeting approach in which peptides are used to deliver modulators of synaptic plasticity to appetite controlling regions of the brain.
The Team
Board of Directors

Mission
We are dedicated to developing effective and safe pharmacotherapies to improve the health and lives of people living with cardiometabolic disease.